NanoString Technologies is a leading provider of life science tools for translational research and molecular diagnostics. Their nCounter Analysis System is a unique digital molecular barcoding technology that enables researchers to analyze gene expression, copy number variation, and protein expression with high sensitivity and precision. The system is used in a wide range of applications, including cancer research, immunology, neuroscience, and infectious disease. NanoString's products are sold to academic, government, and biopharmaceutical customers worldwide. The company was founded in 2003 and is headquartered in Seattle, Washington.